Details for New Drug Application (NDA): 016161
✉ Email this page to a colleague
NDA 016161 describes SYNALAR-HP, which is a drug marketed by Eurofarma and is included in one NDA. Additional details are available on the SYNALAR-HP profile page.
The generic ingredient in SYNALAR-HP is fluocinolone acetonide. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
The generic ingredient in SYNALAR-HP is fluocinolone acetonide. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 016161
| Tradename: | SYNALAR-HP |
| Applicant: | Eurofarma |
| Ingredient: | fluocinolone acetonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016161
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.2% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
